{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00608023","recordId":"NCT00608023","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00608023-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00608023.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00608023.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2008-01-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2008-01-23","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"12e98db2ec3c733309e7a0ed1757dc6502526f82f1cc8af1a4f4281fdd01bbc0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-11-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2011-11-22","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"05edc770a8b22d48ba0cc0786d9113f1a43a75ac19333752e69a4f4e45cb4385","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Outcome Measures","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2013-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2013-11-25","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"b13b06f1ea0798629a4b43c7bd16fcdec4c9dc7dc93b3b7bf1af3f854f39643e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2013-11-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2013-11-27","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"bd416e533aab2bdc7ceb5cf757748cf2b7acbdf8498453ef37c05c0fce8e0d4a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2014-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2014-03-27","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"f57cc52ec770a4eedbb4fe454c6b1ee3dc86dd6f2f6ec9823d62905e6ceb8628","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2022-03-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2022-03-29","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"0b35352604ec39a39acbd83e0cbbbb3ba73d04d766558cfc6aadb8cfe4ea6b3b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","More Information","Study Description","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2022-03-30","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"6b7efe6ea71363fd906bc70a8e03f917d36c7836df25d11c36243b3e08a33ce3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","IPDSharing","Limitations and Caveats","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2022-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2022-09-16","publishedAt":"2026-08-23","recordId":"NCT00608023","recordSha256":"12384bdc9ee3335b002f715019b68457abb1254d2fa8dde0e210961df86b1177","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00608023?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"19467b19e3ae4a9498121cc39329448566ba245603c359fbc1fd6f0e78feec4d"}}